miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-31-5p | ||||
miRNA Stemloop AC | MI0000089 | ||||
miRNA Stemloop ID | hsa-mir-31 | ||||
Sequence | aggcaagaugcuggcauagcu | ||||
TTD Target(s) Regulated by This miRNA | Proto-oncogene c-Ret (RET) | Successful Target | Target Info | [1] | |
Proto-oncogene c-Src (SRC) | Successful Target | Target Info | [2] | ||
Protein kinase C epsilon (PRKCE) | Successful Target | Target Info | [3] | ||
Proto-oncogene c-Met (MET) | Successful Target | Target Info | [2] | ||
Extracellular calcium-sensing receptor (CASR) | Successful Target | Target Info | [4] | ||
Thromboxane A2 receptor (TBXA2R) | Successful Target | Target Info | [5] | ||
Intercellular adhesion molecule ICAM-1 (ICAM1) | Successful Target | Target Info | [6] | ||
Cyclin-dependent kinase 1 (CDK1) | Clinical trial Target | Target Info | [7] | ||
Integrin alpha-5 (ITGA5) | Clinical trial Target | Target Info | [8] | ||
Dickkopf-related protein 1 (DKK1) | Clinical trial Target | Target Info | [9] | ||
Dystrophin (DMD) | Clinical trial Target | Target Info | [10] | ||
E-selectin (SELE) | Clinical trial Target | Target Info | [6] | ||
Stromal cell-derived factor 1 (CXCL12) | Clinical trial Target | Target Info | [1] | ||
Interleukin-25 (IL25) | Clinical trial Target | Target Info | [11] | ||
Transforming protein RhoA (RHOA) | Discontinued Target | Target Info | [12] | ||
Large tumor suppressor homolog 2 (LATS2) | Literature-reported Target | Target Info | [13] | ||
MEK kinase kinase 4 (MAP4K4) | Patented-recorded Target | Target Info | [2] | ||
Matrix metalloproteinase-16 (MMP-16) | Literature-reported Target | Target Info | [14] | ||
X-ray repair cross-complementing 5 (Ku80) | Literature-reported Target | Target Info | [15] | ||
Excitatory amino acid transporter 2 (SLC1A2) | Literature-reported Target | Target Info | [16] | ||
Protein C-ets-1 (ETS1) | Literature-reported Target | Target Info | [1] | ||
DNA mismatch repair protein Mlh1 (MLH1) | Literature-reported Target | Target Info | [17] | ||
GTPase activating protein (RASA1) | Literature-reported Target | Target Info | [18] | ||
T-lymphoma invasion and metastasis 1 (TIAM1) | Literature-reported Target | Target Info | [19] | ||
Transcription factor E2F2 (E2F2) | Literature-reported Target | Target Info | [20] | ||
Stathmin-1 (STMN1) | Literature-reported Target | Target Info | [21] | ||
Protein(s) Regulated by This miRNA | Actin-related protein 2/3 complex subunit 5 | Regulated Protein | [1] | ||
AF4/FMR2 family member 1 | Regulated Protein | [23] | |||
AT-rich interactive domain-containing protein 1A | Regulated Protein | [24] | |||
ATP-binding cassette sub-family B member 9 | Regulated Protein | [25] | |||
BRCA2-interacting transcriptional repressor EMSY | Regulated Protein | [26] | |||
Complement C1q and tumor necrosis factor-related protein 9A | Regulated Protein | [27] | |||
Dapper homolog 3 | Regulated Protein | [9] | |||
Dedicator of cytokinesis protein 1 | Regulated Protein | [29] | |||
DNA replication licensing factor MCM2 | Regulated Protein | [7] | |||
DNA-binding protein SATB2 | Regulated Protein | [31] | |||
Forkhead box protein O3 | Regulated Protein | [32] | |||
Forkhead box protein P3 | Regulated Protein | [33] | |||
Frizzled-3 | Regulated Protein | [1] | |||
Guanine nucleotide-binding protein subunit alpha-13 | Regulated Protein | [34] | |||
Homeobox protein Hox-C13 | Regulated Protein | [1] | |||
Hypoxia-inducible factor 1-alpha inhibitor | Regulated Protein | [35] | |||
Juxtaposed with another zinc finger protein 1 | Regulated Protein | [1] | |||
Krueppel-like factor 13 | Regulated Protein | [1] | |||
Mothers against decapentaplegic homolog 4 | Regulated Protein | [36] | |||
Myosin phosphatase Rho-interacting protein | Regulated Protein | [1] | |||
Nuclear factor of activated T-cells 5 | Regulated Protein | [1] | |||
Protein CREG1 | Regulated Protein | [37] | |||
Protein numb homolog | Regulated Protein | [1] | |||
Protein sprouty homolog 1 | Regulated Protein | [38] | |||
Protein sprouty homolog 3 | Regulated Protein | [38] | |||
Protein sprouty homolog 4 | Regulated Protein | [38] | |||
Radixin | Regulated Protein | [1] | |||
Radixin | Regulated Protein | [39] | |||
Ras-related protein Rab-27A | Regulated Protein | [2] | |||
Rho-related BTB domain-containing protein 1 | Regulated Protein | [41] | |||
Serine/threonine-protein kinase 40 | Regulated Protein | [42] | |||
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform | Regulated Protein | [43] | |||
Sphingosine-1-phosphate phosphatase 2 | Regulated Protein | [36] | |||
Sprouty-related, EVH1 domain-containing protein 1 | Regulated Protein | [38] | |||
Sprouty-related, EVH1 domain-containing protein 2 | Regulated Protein | [38] | |||
Transcription factor SOX-4 | Regulated Protein | [44] | |||
Transcription factor Sp7 | Regulated Protein | [45] | |||
Transcriptional repressor protein YY1 | Regulated Protein | [1] | |||
Ubiquitin carboxyl-terminal hydrolase BAP1 | Regulated Protein | [46] | |||
Wiskott-Aldrich syndrome protein family member 3 | Regulated Protein | [47] | |||
References | |||||
REF 1 | A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009 Jun 12;137(6):1032-46. | ||||
REF 2 | Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. Oncotarget. 2012 Sep;3(9):1011-25. | ||||
REF 3 | MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon). J Biol Chem. 2013 Mar 22;288(12):8750-61. | ||||
REF 4 | miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res. 2010 Feb 15;70(4):1635-44. | ||||
REF 5 | Deficiency of the microRNA-31-microRNA-720 pathway in the plasma and endothelial progenitor cells from patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):857-69. | ||||
REF 6 | Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol. 2010 Jan 1;184(1):21-5. | ||||
REF 7 | Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. Cancer Res. 2013 Feb 1;73(3):1232-44. | ||||
REF 8 | MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science. 2009 Jun 26;324(5935):1710-3. | ||||
REF 9 | Cigarette smoke induces C/EBP--mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS One. 2010 Oct 29;5(10):e13764. | ||||
REF 10 | miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep. 2011 Feb;12(2):136-41. | ||||
REF 11 | The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis. Mucosal Immunol. 2017 Jul;10(4):983-995. | ||||
REF 12 | MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol. 2008 Nov;28(22):6773-84. | ||||
REF 13 | A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006 Mar 24;124(6):1169-81. | ||||
REF 14 | microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res. 2009 May 7;1269:158-65. | ||||
REF 15 | K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression. Int J Cancer. 2015 Mar 15;136(6):1263-75. | ||||
REF 16 | Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants. Aging Cell. 2017 Apr;16(2):262-272. | ||||
REF 17 | MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells. Tumour Biol. 2013 Jun;34(3):1959-65. | ||||
REF 18 | MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol Chem. 2013 Mar 29;288(13):9508-18. | ||||
REF 19 | miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem. 2010 Nov 12;285(46):35293-302. | ||||
REF 20 | Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2. Oncotarget. 2016 Jun 14;7(24):36577-36589. | ||||
REF 21 | P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane. Oncoscience. 2015 Mar 23;2(3):294-308. | ||||
REF 22 | A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009 Jun 12;137(6):1032-46. | ||||
REF 23 | MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.J Ovarian Res. 2015 Aug 12;8:56. | ||||
REF 24 | MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.Gynecol Oncol. 2014 Jul;134(1):129-37. | ||||
REF 25 | MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9.Cancer Lett. 2014 Feb 28;343(2):249-57. | ||||
REF 26 | The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.Mol Cell. 2014 Mar 6;53(5):806-18. | ||||
REF 27 | miR-31 Links Lipid Metabolism and Cell Apoptosis in Bacteria-Challenged Apostichopus japonicus via Targeting CTRP9.Front Immunol. 2017 Mar 13;8:263. | ||||
REF 28 | Cigarette smoke induces C/EBP--mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS One. 2010 Oct 29;5(10):e13764. | ||||
REF 29 | Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31.Neuropathol Appl Neurobiol. 2017 Aug;43(5):419-432. | ||||
REF 30 | Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. Cancer Res. 2013 Feb 1;73(3):1232-44. | ||||
REF 31 | The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts.Cell Cycle. 2010 Nov 1;9(21):4387-98. | ||||
REF 32 | Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling. PLoS Genet. 2016 Aug 19;12(8):e1006244. | ||||
REF 33 | Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression.Eur J Immunol. 2009 Jun;39(6):1608-18. | ||||
REF 34 | MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.Mol Cancer. 2015 Mar 26;14:67. | ||||
REF 35 | MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism.FASEB J. 2012 Aug;26(8):3140-7. | ||||
REF 36 | Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.Cancer Gene Ther. 2015 Dec;22(12):564-72. | ||||
REF 37 | MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes.Exp Cell Res. 2013 May 1;319(8):1165-75. | ||||
REF 38 | MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. J Clin Invest. 2016 Jan;126(1):349-64. | ||||
REF 39 | Human miR-31 targets radixin and inhibits migration and invasion of glioma cells.Oncol Rep. 2012 Mar;27(3):700-6. | ||||
REF 40 | Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. Oncotarget. 2012 Sep;3(9):1011-25. | ||||
REF 41 | The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.Int J Oncol. 2013 Feb;42(2):676-82. | ||||
REF 42 | MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40.J Immunol. 2013 Jan 15;190(2):678-88. | ||||
REF 43 | MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest. 2010 Apr;120(4):1298-309. | ||||
REF 44 | SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.Mol Cancer. 2015 Feb 3;14:24. | ||||
REF 45 | MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.Gene. 2013 Sep 15;527(1):321-31. | ||||
REF 46 | BAP1 suppresses lung cancer progression and is inhibited by miR-31.Oncotarget. 2016 Mar 22;7(12):13742-53. | ||||
REF 47 | WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade.Int J Cancer. 2011 Sep 15;129(6):1331-43. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.